Sarah is the Chief Scientific Officer at CHARM. Sarah has >20 years of experience in the pharma & biotech industry and has held senior positions at Pfizer, Vertex and Merck.
In these roles, Sarah has led multi-disciplinary teams and delivered numerous clinical candidates across a wide range of therapeutic areas.
Sarah is an organic chemist by training, conducting her Ph.D. with Professor J C Anderson at the University of Nottingham before undertaking postdoctoral studies with Professor P A Wender at Stanford University as a visiting Fulbright Scholar.
